glutathione toxicity What You ACTUALLY Need to Know About Mold and Oxidative stress & glutathione: Symptoms,

Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions

5-amino-1MQ has yet to enter clinical trials and accordingly is yet to be approved for human use by the United States Food and Drug Administration (USFDA)

Vitamin B12 injections offer many benefits

5-Amino-1MQ is a small molecule designed to inhibit NNMT

doi: 10.1016/j.jocrd.2020.100529 19 LiberatiAAltmanDGTetzlaffJMulrowCGtzschePCIoannidisJPet al

Injection Technique Same-Day, Separate-Site The most-described community pattern for two-compound stacks is same-day, separate-site injection: both compounds delivered the same day each week, but at different subcutaneous sites